EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair

Renata Perlikowska, Małgorzata Domowicz iD, Agnieszka Śliwińska iD, Mariusz Stasiołek iD

International Journal of Molecular Sciences · 05.05.2026 · 27 (9) · 4122

DOI: 10.3390/ijms27094122 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.05.2026. Verfasst von Renata Perlikowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nucleic Acid Biochemistry, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland. Hauptthemen laut MEDLINE: Multiple Sclerosis, Signal Transduction, Analgesics, Opioid. Die Arbeit nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system (CNS) characterized by persistent inflammation, demyelination, and progressive neurodegeneration, driven largely by aberrant activation of T and B lymphocytes that infiltrate the CNS and cause myelin and axonal damage, leading to neurological impairment. Although current therapies broadly suppress immune activity and reduce relapse rates, their effects on neurodegenerative processes remain limited. Also, the safety profile of disease-modifying therapies (DMTs) may become problematic, especially in older patients with comorbidities and/or advanced disability. Emerging data suggest that opioid signaling may exert immunomodulatory, remyelinating, and neuroprotective effects, representing a novel and underexplored therapeutic avenue. Given that current MS therapies primarily target inflammation but fail to promote myelin repair or prevent neurodegeneration, opioid signaling emerges as a novel and underexplored pathway with potential benefits for immunomodulation and remyelination, as well as possible neuroprotective effects. Despite concerns about classical opioid-related adverse effects, accumulating evidence shows that opioid-mediated interventions have been associated with reduced inflammatory activity, attenuation of demyelination, and enhanced neuronal survival and have shown therapeutic benefit in MS. Although current findings are largely preclinical, they provide a compelling rationale for further investigation of the opioid system as a potential adjunctive or novel therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisSignal TransductionAnalgesics, OpioidHumansAnimalsReceptors, OpioidMyelin SheathRemyelinationNeuroprotective Agents

Stichwörter der Autor:innen

immunomodulationmultiple sclerosisneuroprotectionopioid signalingremyelination

Substanzen

Analgesics, OpioidReceptors, OpioidNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Nucleic Acid Biochemistry, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland.
  • Department of Neurology, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland.

ORCID-Profile: Małgorzata Domowicz, Agnieszka Śliwińska, Mariusz Stasiołek

Förderung

  • Medical University of Lodz

Zitieren

APA

Perlikowska, R., Domowicz, M., Śliwińska, A., & Stasiołek, M. (2026). Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair. International Journal of Molecular Sciences, 27(9), 4122. https://doi.org/10.3390/ijms27094122

Vancouver

Perlikowska R, Domowicz M, Śliwińska A, Stasiołek M. Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair. International Journal of Molecular Sciences. 2026;27(9):4122. doi:10.3390/ijms27094122

BibTeX
@article{Perlikowska2026,
  author = {Perlikowska, Renata and Domowicz, Małgorzata and Śliwińska, Agnieszka and Stasiołek, Mariusz},
  title = {Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {4122},
  doi = {10.3390/ijms27094122}
}
Kostenlos starten →